- Investing Ideas
- /
- French Top Stock Picks from Analysts
French Top Stock Picks from Analysts
Results
100
1 new
Companies which are more than 50% undervalued based on analyst price target.
100 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
PEUG | €75.20 | 1.5% | -30.1% | €1.9b | €115.00 | PE16.6x | E15.8% | 4.3% | Diversified Financials | ||
ALHG New | €1.46 | 4.8% | n/a | €1.4b | €2.20 | PE111.4x | E70.5% | 4.1% | Media | ||
VLTSA | €7.78 | 6.1% | -0.8% | €1.0b | €12.01 | PE30.5x | E21.1% | n/a | Utilities | ||
VLA | €3.78 | 2.1% | 12.4% | €613.1m | €6.69 | PS3.9x | E-13.6% | n/a | Pharmaceuticals & Biotech | ||
ATO | €0.0034 | 36.0% | -99.9% | €608.7m | €0.09 | PS0.06x | E121.4% | 0% | Software | ||
ETL | €1.22 | -29.0% | -68.4% | €579.2m | €2.12 | PS0.5x | E92.1% | 0% | Media | ||
EQS | €37.00 | -2.0% | -23.2% | €556.2m | €58.83 | PE13.2x | E9.1% | 3.4% | Healthcare | ||
ABVX | €7.37 | 10.8% | -36.6% | €467.1m | €29.34 | PS51.7x | E19.5% | n/a | Pharmaceuticals & Biotech | ||
MEDCL | €13.50 | -7.2% | 49.8% | €401.7m | €22.23 | PS30.4x | E114.3% | n/a | Pharmaceuticals & Biotech | ||
WAGA | €14.54 | 0.7% | -25.8% | €359.0m | €27.75 | PS7.9x | E-9.6% | n/a | Energy | ||
CO | €0.79 | -8.9% | -98.1% | €315.0m | €2.08 | PE0.2x | E-81.0% | 0% | Consumer Retailing | ||
IVA | €2.42 | 8.0% | -20.4% | €231.5m | €7.10 | PS12x | E31.7% | n/a | Pharmaceuticals & Biotech | ||
ALSEN | €0.61 | 0% | -23.8% | €183.8m | €2.50 | PS29.9x | E-31.5% | n/a | Pharmaceuticals & Biotech | ||
GNFT | €3.65 | -6.4% | 8.1% | €182.0m | €9.45 | PE8.2x | E45.2% | n/a | Pharmaceuticals & Biotech | ||
IPH | €2.10 | 9.6% | -10.6% | €176.0m | €6.14 | PS5.2x | E50.9% | n/a | Pharmaceuticals & Biotech | ||
PARP | €18.00 | -0.6% | -13.0% | €173.1m | €30.80 | PE157.3x | n/a | 1.8% | Consumer Services | ||
NANO | €3.62 | -8.5% | -42.1% | €171.4m | €11.17 | PS4.1x | E36.5% | n/a | Pharmaceuticals & Biotech | ||
LHYFE | €3.46 | 3.0% | -27.6% | €165.8m | €5.22 | PS63.7x | E21.1% | n/a | Energy | ||
ALFPC | €100.00 | -1.0% | -14.9% | €164.4m | €174.50 | PE4.9x | E-30.6% | 2.2% | Consumer Durables | ||
ALFRE | €2.80 | 4.5% | -17.9% | €158.2m | €4.70 | PE10.2x | E15.3% | 2.9% | Commercial Services | ||
ALPUL | €18.68 | -4.9% | 33.6% | €153.8m | €30.78 | PE11.2x | E-22.2% | 0% | Media | ||
OSE | €6.90 | -4.7% | 106.9% | €150.9m | €15.37 | PE3.3x | E-77.4% | n/a | Pharmaceuticals & Biotech | ||
ARVEN | €4.08 | 1.0% | -50.8% | €141.9m | €8.50 | PS14.1x | E45.5% | n/a | Utilities | ||
FDE | €22.00 | 0.5% | -48.3% | €116.1m | €51.67 | PE11.9x | E20.5% | n/a | Energy |